Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 22 | ECE2010 | Next issue

12th European Congress of Endocrinology

Poster Presentations

Cardiovascular endocrinology and lipid metabolism

Previous section
Bone/Calcium
Table of contents
Next section
Clinical case reports and clinical practice

ea0022p123 | Cardiovascular endocrinology and lipid metabolism

Interrelation between bone mineral density and lipid profile in postmenopausal women

ea0022p124 | Cardiovascular endocrinology and lipid metabolism

Levels of adiponectin and tumor necrosis factor-alpha in members of families with familial combined hyperlipidemia

ea0022p125 | Cardiovascular endocrinology and lipid metabolism

Cardiovascular disease and risk factors in patients with type 2 diabetes in IRAN

ea0022p126 | Cardiovascular endocrinology and lipid metabolism

The effect of erythropoietin treatment on insulin resistance and inflammatory markers in patients on maintenance hemodialysis

ea0022p127 | Cardiovascular endocrinology and lipid metabolism

Subjects homozygous for the BCL1 polymorphism of glucocorticoid receptor gene may have an increased risk for impaired endothelial function

ea0022p128 | Cardiovascular endocrinology and lipid metabolism

Leptin and its associations with complications of acute myocardial infarction in patients with the metabolic syndrome

ea0022p129 | Cardiovascular endocrinology and lipid metabolism

Obesity and metabolic syndrome during the menopausal transition of women in Serbia

ea0022p130 | Cardiovascular endocrinology and lipid metabolism

The effects of adiponectin gene polymorphisms on the progression of carotid intima-media thickness

ea0022p131 | Cardiovascular endocrinology and lipid metabolism

Associations between the metabolic syndrome and bone mineral density in Ukrainian women in postmenopausal period

ea0022p132 | Cardiovascular endocrinology and lipid metabolism

Prevalence of metabolic syndrome in a working population of strategic services

ea0022p133 | Cardiovascular endocrinology and lipid metabolism

Are the thyroid functions associated with widespread of acute coronary syndromes?

ea0022p134 | Cardiovascular endocrinology and lipid metabolism

Effects of cross-sex hormone treatment in young transsexual subjects

ea0022p135 | Cardiovascular endocrinology and lipid metabolism

Insulin secretion and HOMA-IR in patients who underwent coronary angiography

ea0022p136 | Cardiovascular endocrinology and lipid metabolism

Serum ferritin and risk of the metabolic syndrome in cross-sex hormone-treated transsexuals

ea0022p137 | Cardiovascular endocrinology and lipid metabolism

FABP4 inhibitor strongly depresses cardiac function

ea0022p138 | Cardiovascular endocrinology and lipid metabolism

Calculation of cardiovascular risk in firefighters

ea0022p139 | Cardiovascular endocrinology and lipid metabolism

Echocardiographic epicardial fat thickness in acromegaly patients

ea0022p140 | Cardiovascular endocrinology and lipid metabolism

Atrial natriuretic peptide (ANP) attenuates lipid peroxidation in anesthetized atherosclerotic male rabbits by reduction of renin-angotensin-aldosterone system (RAAS) activity

ea0022p141 | Cardiovascular endocrinology and lipid metabolism

Serum IGF1 levels correlate to improvement of functional independence after ischemic stroke

ea0022p142 | Cardiovascular endocrinology and lipid metabolism

Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial

ea0022p143 | Cardiovascular endocrinology and lipid metabolism

Osteopontin, adiponectin and peripherical arterial disease in patients with type 2 diabetes

ea0022p144 | Cardiovascular endocrinology and lipid metabolism

Clinical approach to hypertensive patients: matter of trust between doctor and patient

ea0022p145 | Cardiovascular endocrinology and lipid metabolism

Ligands of receptor for advanced glycation end-products in stable coronary artery disease: their potential contribution to atherogenesis exceeds beyond diabetes mellitus

ea0022p146 | Cardiovascular endocrinology and lipid metabolism

Acromegaly and endothelial dysfunction: is there any relation between?

ea0022p147 | Cardiovascular endocrinology and lipid metabolism

Gender variations of serum Paraoxonase-1 activities in healthy young men and women: association with carotid intimae media thickness

ea0022p148 | Cardiovascular endocrinology and lipid metabolism

Searching for the metabolic syndrome criteria in young adults with hypogonadism

ea0022p149 | Cardiovascular endocrinology and lipid metabolism

Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction

ea0022p150 | Cardiovascular endocrinology and lipid metabolism

Genetic polymorphisms associated with cardiovascular risk correlate with dyslipidaemia in healthy postmenopausal women

ea0022p151 | Cardiovascular endocrinology and lipid metabolism

Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?

ea0022p152 | Cardiovascular endocrinology and lipid metabolism

Relationship between serum IL-12 and p40 subunit concentrations and lipid parameters in obese subjects

ea0022p153 | Cardiovascular endocrinology and lipid metabolism

Heart rate variability in adults with hypopituitarism and severe growth hormone deficiency

ea0022p154 | Cardiovascular endocrinology and lipid metabolism

Increased plasma resistin concentrations are associated with atherogenic small, dense low-density lipoproteins in patients with type-2 diabetes

ea0022p155 | Cardiovascular endocrinology and lipid metabolism

Increased plasma viscosity is a predictor of high cardiovascular risk in women with PCOS

ea0022p156 | Cardiovascular endocrinology and lipid metabolism

The impact of testosterone replacement therapy on endothelial function in hypogonadal men with type 2 diabetes

ea0022p157 | Cardiovascular endocrinology and lipid metabolism

Alterations of plasminogen activator inhibitor-1, myeloperoxidase and matrix metalloproteinase-9 in coronary artery disease patients with type-2 diabetes mellitus

ea0022p158 | Cardiovascular endocrinology and lipid metabolism

Osteoprotegerin and angiotensin II in type 2 diabetes

ea0022p159 | Cardiovascular endocrinology and lipid metabolism

Changes in serum concentrations and tissue expression of fibroblast growth factor-21 during and after elective major cardiac surgery

ea0022p160 | Cardiovascular endocrinology and lipid metabolism

MRI-assessed visceral adipose tissue (VAT) in different lipodystrophic (LD) syndromes

ea0022p161 | Cardiovascular endocrinology and lipid metabolism

Possibility for the Metformin administration in post-infarction period in patients with the 2-nd type of DM

ea0022p162 | Cardiovascular endocrinology and lipid metabolism

The effect of testesterone replacement therapy on HDL subfraction levels in hypogonadotropic hypogonadism

ea0022p163 | Cardiovascular endocrinology and lipid metabolism

Pitfalls in endocrine assessment of systemic hypertension in young people

ea0022p164 | Cardiovascular endocrinology and lipid metabolism

Correlation of plasma B-type natriuretic peptide (BNP) levels with electrocardiographic (ECG) signs of right ventricular strain in patients with acute pulmonary embolism

ea0022p165 | Cardiovascular endocrinology and lipid metabolism

Male sexuality and cardiovascular risk: a cohort study in patients with erectile dysfunction

ea0022p166 | Cardiovascular endocrinology and lipid metabolism

CRH and Urn2 regulate NO bioavailability, ROS levels and antioxidant defence systems in endothelial cells

ea0022p167 | Cardiovascular endocrinology and lipid metabolism

Structural and functional carotid wall alterations in controlled versus active acromegaly

ea0022p168 | Cardiovascular endocrinology and lipid metabolism

Sexual dimorphism of cardiovascular ischemia susceptibility is mediated by heme-oxigenase synthase

ea0022p169 | Cardiovascular endocrinology and lipid metabolism

Bcl1 polymorphysm of glucocorticoid receptor gene in coronary artery disease

ea0022p170 | Cardiovascular endocrinology and lipid metabolism

Formation of neutralizing anti human growth hormone (hGH) antibodies does not explain the lack of IGF1 increase after recombinant hGH treatment in mice

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more